Author:
Mateu-Gelabert Pedro,Guarino H.,Quinn K.,Meylakhs P.,Campos S.,Meylakhs A.,Berbesi D.,Toro-Tobón D.,Goodbody E.,Ompad D.C.,Friedman S. R.
Funder
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference45 articles.
1. Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickeran P. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5:e1192–207.
2. Merz F. United Nations Office on Drugs and Crime. World Drug Report 2017.
https://www.unodc.org/wdr2017/index.html
. Accessed 2 April 2018.
3. World Health Organization. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. 2012.
http://apps.who.int/iris/bitstream/handle/10665/77969/9789241504379_eng.pdf;jsessionid=1ABEDB253458AEBFA58D90ED7212F250?sequence=1
. Accessed 4 April 2018.
4. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375:1014–28.
5. Degenhardt L, Mathers B, Vickerman P, Rhodes T, Latkin C, Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285–301.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献